Pandorum Technologies
Develops tunable, regenerative exosome therapies for tissue health, disease, and degeneration
$18MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops tunable, regenerative exosome therapies for tissue health, disease, and degeneration